Allspring Global Investments Holdings, LLC Cytokinetics Inc Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 87,812 shares of CYTK stock, worth $4.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

87,812

Previous 3,416 2470.61%

Holding current value

$4.82 Million

Previous $239,000 1890.38%

% of portfolio

0.01%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$47.86 - $75.05 $4.04 Million - $6.33 Million	84,396 Added 2470.61%	87,812 $4.76 Million
Q1 2024 Apr 18, 2024	BUY	$63.75 - $108.06 $35,572 - $60,297	558 Added 19.52%	3,416 $239,000
Q4 2023 Jan 25, 2024	SELL	$26.88 - $83.49 $44,190 - $137,257	-1,644 Reduced 36.52%	2,858 $238,000
Q3 2023 Oct 27, 2023	BUY	$29.46 - $36.61 $132,628 - $164,818	4,502 New	4,502 $132,000
Q2 2023 Jul 18, 2023	SELL	$32.62 - $40.75 $5.7 Million - $7.13 Million	-174,881 Reduced 87.48%	25,036 $816,000
Q1 2023 Apr 13, 2023	BUY	$33.36 - $45.71 $205,397 - $281,436	6,157 Added 3.18%	199,917 $7.04 Million
Q4 2022 Jan 23, 2023	BUY	$35.77 - $51.11 $50,256 - $71,809	1,405 Added 0.73%	193,760 $0
Q3 2022 Oct 26, 2022	BUY	$38.54 - $54.52 $249,045 - $352,308	6,462 Added 3.48%	192,355 $9.32 Million
Q2 2022 Jul 25, 2022	SELL	$33.93 - $48.92 $1.05 Million - $1.52 Million	-31,055 Reduced 14.31%	185,893 $7.3 Million
Q1 2022 May 02, 2022	SELL	$29.74 - $46.0 $41,070 - $63,526	-1,381 Reduced 0.63%	216,948 $7.99 Million
Q4 2021 Jan 28, 2022	BUY	$34.35 - $46.38 $7.5 Million - $10.1 Million	218,329 New	218,329 $9.95 Million

Others Institutions Holding CYTK

# of Institutions

406

Shares Held

126M

Call Options Held

3.29M

Put Options Held

2.01M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.17B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Cytokinetics Inc Transaction History